Medicamen Biotech Limited (NSE:MEDICAMEQ)
India · Delayed Price · Currency is INR 308.00
-11.95 (-3.73%)
Sep 24, 2026, 2:42 PM IST
Medicamen Biotech Market Cap
Medicamen Biotech has a market cap or net worth of 4.39 billion as of September 23, 2026. Its market cap has increased by 7.30% in one year.
Market Cap
4.39B
Enterprise Value
4.56B
Revenue
2.06B
Ranking
n/a
PE Ratio
45.73
Stock Price
308.00
ChartMarket Cap Chart
Since January 12, 2005, Medicamen Biotech's market cap has increased from 108.49M to 4.39B, an increase of 3,949.26%. That is a compound annual growth rate of 18.59%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 4.39B | -4.83% |
| Dec 31, 2025 | 4.62B | -28.94% |
| Dec 31, 2024 | 6.50B | -14.77% |
| Dec 29, 2023 | 7.62B | -27.09% |
| Dec 30, 2022 | 10.45B | -3.50% |
| Dec 31, 2021 | 10.83B | 86.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Jagsonpal Pharmaceuticals | 14.95B |
| Anlon Healthcare | 13.95B |
| Sigachi Industries | 11.89B |
| Bafna Pharmaceuticals | 7.65B |
| Amanta Healthcare | 7.20B |
| Valiant Laboratories | 6.90B |
| Nectar Lifesciences | 2.12B |
| Brooks Laboratories | 1.74B |